- Home
- Healthcare professionals
- ACE Technology Guidances
- Drug Guidance
- Solifenacin for treating overactive bladder
Drug guidance
Solifenacin for treating overactive bladder
Condition
Urological
1 October 2018
Published on 01 Oct 2018
Last Updated on 01 Oct 2018
Guidance Recommendation
The Ministry of Health's Drug Advisory Committee has recommended:
Solifenacin 5 mg tablet for treating overactive bladder.
Subsidy status
Solifenacin 5 mg tablet is recommended for inclusion on the MOH Standard Drug List (SDL).